๐Ÿ Snakebite & Envenomation

National Protocol WHO SEARO ICMR Tintinalli's
India's "Big Four" 20-WBCT ยท ASV Dosing Neurotoxic vs Haemotoxic Tintinalli's 9th Ed ยท Rosen's 10th Ed ยท National Snakebite Management Protocol (India) 2009/2017 ยท WHO SEARO 2016
๐Ÿ“… Last reviewed July 2026 ยท Next review January 2027 ยท Compiled by Dr. Anmol Srivastava Anaesthesia, Emergency Medicine & Critical Care Medicine ยท Reviewed by Dr. Tanya Chawla Anaesthesia & Critical Care
๐Ÿ“• 1 ยท Tintinalli's Emergency Medicine, 9th Ed

Tintinalli's Summary โ€” Treat the Patient, Not the Snake

"The management of venomous snakebite rests on a single principle: antivenom is indicated only when there is evidence of systemic or significant local envenomation, not for the bite itself. Many bites are 'dry' โ€” no venom is injected. The clinician's task is to recognise the envenomation syndrome, support the airway and circulation, and administer adequate antivenom promptly when indicated, while discarding the harmful first-aid traditions of tourniquets, incision and suction."

Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9th Ed. McGraw-Hill 2020. Chapter: Reptile Bites / Venomous Animal Injuries.

The Core Message (Tintinalli's)

  • Antivenom is the only specific treatment โ€” indicated for systemic envenomation (neurotoxicity, coagulopathy, haemodynamic instability) or severe progressive local envenomation.
  • Not every bite needs antivenom โ€” observe for the evolving syndrome; dry bites and bites by non-venomous snakes do not.
  • Abandon harmful first aid โ€” no tourniquets (cause ischaemia/gangrene, sudden venom bolus on release), no incision, no suction, no electric shock, no ice, no herbal poultices.
  • Airway and ventilatory support can be life-saving and buys time in neurotoxic envenomation โ€” patients fully recover with ventilation while antivenom and the body clear the toxin.

๐Ÿš‘ Correct First Aid โ€” "Do It R.I.G.H.T."

Reassure ยท Immobilise (splint the limb like a fracture, keep below/at heart level) ยท Get to Hospital immediately ยท Tell the doctor of any systemic symptoms. No tourniquet, no cutting, no sucking.

๐Ÿ“˜ 2 ยท Rosen's Emergency Medicine, 10th Ed

Rosen's โ€” Venom Composition & the Two Syndromes

๐Ÿ”ฌ How envenomation causes its two syndromes
TriggerEnvenomation by India's Big Four (cobra ยท krait ยท Russell's ยท saw-scaled)
Venom enzymes spread locally & systemically
NeurotoxicElapids (cobra, krait): pre/post-synaptic NMJ blockade โ†’ descending flaccid paralysis โ†’ respiratory failure
HaemotoxicVipers (Russell's, saw-scaled): clotting-cascade activation โ†’ VICC (incoagulable blood) + local necrosis โ†’ bleeding, AKI, shock

"Snake venoms are complex enzymatic cocktails. Elapid venoms (cobras, kraits) are predominantly neurotoxic, producing a descending flaccid paralysis through pre- and post-synaptic blockade at the neuromuscular junction. Viperid venoms (Russell's viper, saw-scaled viper) are predominantly haemotoxic and cytotoxic, activating the clotting cascade to consume fibrinogen โ€” producing a venom-induced consumption coagulopathy โ€” alongside local tissue necrosis and capillary leak."

Rosen's Emergency Medicine: Concepts and Clinical Practice, 10th Ed. Elsevier 2023. Chapter: Reptile Envenomations.

๐ŸŸฃ Neurotoxic (Elapids โ€” Cobra, Krait)

  • Onset: cobra fast; krait often delayed (bite at night while asleep, symptoms in early morning)
  • Ptosis is the earliest sign โ†’ ophthalmoplegia โ†’ bulbar weakness โ†’ descending paralysis โ†’ respiratory failure
  • Krait: minimal/no local signs; abdominal pain; may have no visible bite mark
  • Cobra: prominent local necrosis + neurotoxicity
  • Treatment: ASV + neostigmine/atropine trial; ventilate โ€” full recovery is the rule with airway support

๐Ÿ”ด Haemotoxic (Vipers โ€” Russell's, Saw-scaled)

  • Venom-induced consumption coagulopathy (VICC): incoagulable blood, bleeding gums/haematuria
  • Local: severe swelling, blistering, necrosis, compartment syndrome
  • Russell's viper: AKI (common, may need dialysis), capillary leak, shock, occasionally neurotoxicity + pituitary infarction (Sheehan-like)
  • Monitoring: the 20-minute whole blood clotting test (20-WBCT)
  • Treatment: ASV until coagulation restored; AKI support
๐Ÿ“˜ Rosen's โ€” India's "Big Four" (and beyond)

The four species responsible for most life-threatening envenomation in India: Indian cobra (Naja naja), common krait (Bungarus caeruleus), Russell's viper (Daboia russelii), and saw-scaled viper (Echis carinatus). Indian polyvalent ASV is raised against these four. Note that other species (e.g. hump-nosed pit viper, some regional kraits) may not respond to standard polyvalent ASV โ€” an important cause of "ASV failure". Venom yield and effect are independent of snake "aggression"; identification is helpful but treatment is syndrome-driven.

๐Ÿ“‹ 3 ยท National Snakebite Protocol & the 20-WBCT

India National Snakebite Management Protocol / WHO SEARO

When to Give Antivenom โ€” Indications for ASV
Give ASV only with evidence of systemic envenomation OR severe local envenomation National Protocol:
Systemic: abnormal 20-WBCT or other coagulopathy/spontaneous bleeding ยท neurotoxicity (ptosis, ophthalmoplegia, bulbar/respiratory weakness) ยท cardiovascular (hypotension, shock) ยท AKI / dark urine (haemoglobinuria/myoglobinuria) ยท significant unexplained anaemia/thrombocytopenia.
Local: swelling involving >half the bitten limb, rapid extension, bites on digits, or extensive blistering/necrosis.

๐Ÿฉธ The 20-Minute Whole Blood Clotting Test (20-WBCT)

The single most useful bedside test for haemotoxic envenomation. Place 2โ€“3 mL of fresh venous blood in a clean, dry glass test tube, leave undisturbed for 20 minutes, then tip once. If the blood is still liquid (does not clot) โ†’ coagulopathy = systemic envenomation โ†’ give ASV. Repeat every 6 hours after ASV until clotting is restored. Must use a glass tube (plastic does not activate clotting); a new clean tube each time.

Neostigmine Trial โ€” Neurotoxic Envenomation
After ASV, in neurotoxic envenomation give a trial of atropine 0.6 mg IV followed by neostigmine 1.5โ€“2.0 mg IV (paediatric 0.04 mg/kg), then neostigmine 0.5 mg + atropine every 30 min. Improvement in ptosis/power (best seen with post-synaptic toxins, e.g. cobra) supports continuing; pre-synaptic toxins (krait, Russell's) respond poorly โ€” do not rely on it, ventilate as needed.
๐Ÿ‡ฎ๐Ÿ‡ณ Indian ED Context โ€” The Realities

Massive burden: India records the highest snakebite mortality globally (~58,000 deaths/year per the "Million Death Study"). Most are rural, agricultural, lower-limb bites; delays from traditional healers are common and deadly.

ASV is polyvalent (covers the Big Four) and is the only ASV widely available โ€” there is no monovalent product in routine use. Regional species not covered by it (hump-nosed pit viper in the southwest) are an important cause of apparent treatment failure.

Krait bites are a classic trap: a villager "bitten while sleeping" who wakes with abdominal pain, ptosis and breathlessness, often with no visible fang marks and no local swelling โ€” maintain high suspicion and check for ptosis.

AKI from Russell's viper is a leading cause of dialysis need; monitor urine output and renal function closely.

๐Ÿ’Š 4 ยท ASV Dosing & Drug Reference

Anti-Snake Venom & Supportive Drugs

ASV Dose (Indian Polyvalent)
Initial dose 8โ€“10 vials IV for systemic envenomation (some protocols 10 vials for neurotoxic/severe viper). Each reconstituted/liquid vial diluted in ~10 mL/kg isotonic fluid (or 100 mL NS) and infused over ~1 hour. National Protocol
Children receive the SAME dose as adults โ€” venom load is independent of body size (same bite, same venom).
Repeat dose: for haemotoxic โ€” repeat 5โ€“10 vials after 6 h if 20-WBCT remains abnormal; for neurotoxic โ€” repeat once after 1โ€“2 h if worsening. Maximum effect is capped โ€” beyond ~20โ€“30 vials with no response, reconsider diagnosis/species coverage rather than escalating endlessly.
DrugRoleDoseNotes
Polyvalent ASVSpecific antivenom8โ€“10 vials IV over 1h; repeat per syndromeSame dose adults & children; only for systemic/severe local envenomation
Adrenaline (1:1000) IMASV anaphylactic reaction0.5 mg IM anterolateral thighKeep drawn up BEFORE starting ASV; first-line for the reaction
NeostigmineNeurotoxic trial (post ASV)1.5โ€“2.0 mg IV load, then 0.5 mg q30 minBest for cobra (post-synaptic); poor for krait/Russell's (pre-synaptic)
AtropineWith neostigmine0.6 mg IV before each neostigmineBlocks muscarinic effects of neostigmine
Tetanus toxoidWound prophylaxisAs per immunisation statusGive once coagulopathy corrected (avoid IM injections while coagulopathic)
IV crystalloidHypotension / capillary leak20 mL/kg boluses, reassessRussell's viper causes capillary leak & shock
โš ๏ธ Avoid in Coagulopathic Snakebite

No IM injections, no arterial punctures, no central lines / chest drains while the blood is incoagulable โ€” they cause uncontrollable bleeding. Give ASV first to correct the coagulopathy. Avoid heparin, aspirin, NSAIDs. Blood products (FFP/cryoprecipitate) are generally NOT first-line โ€” adequate ASV allows the liver to regenerate clotting factors; reserve products for life-threatening bleeding after adequate ASV.

๐Ÿ—‚ 5 ยท Clinical Flowchart

Step-by-Step Management Algorithm

1

Resuscitate & assess (ABC)

  • Airway/breathing โ€” neurotoxic bites can cause respiratory failure; prepare to intubate & ventilate.
  • Remove constricting items/any tourniquet slowly; immobilise the limb (splint), keep at heart level.
  • Two IV lines; bloods (CBC, coagulation, RFT, CK, urine for blood).
2

Look for the envenomation syndrome

  • 20-WBCT now (and 6-hourly) โ†’ coagulopathy = haemotoxic.
  • Check for ptosis / ophthalmoplegia / bulbar & respiratory weakness โ†’ neurotoxic.
  • BP, urine output, local swelling extent. Mark the leading edge of swelling with time.
3

Give ASV if indicated

  • Systemic or severe local envenomation โ†’ 8โ€“10 vials ASV over 1 h (have adrenaline drawn up).
  • Monitor closely for an ASV reaction during/after the infusion.
  • Neurotoxic โ†’ add atropine + neostigmine trial; ventilate as needed.
4

Reassess & repeat

  • Repeat 20-WBCT at 6 h โ†’ still incoagulable โ†’ repeat ASV 5โ€“10 vials.
  • Neurotoxic worsening at 1โ€“2 h โ†’ repeat ASV once; otherwise support ventilation (full recovery expected).
  • Russell's viper โ†’ watch renal function/urine output; arrange dialysis if AKI.
5

Supportive care & observation

  • Tetanus prophylaxis once coagulation normal; wound care; watch for compartment syndrome (measure pressures โ€” fasciotomy only with confirmed raised pressure AND corrected coagulopathy).
  • Observe asymptomatic/"dry bite" patients โ‰ฅ24 h (krait/Russell's can be delayed) before discharge.
  • Counsel on delayed serum sickness (5โ€“14 days) and when to return.
๐Ÿ”ฌ 6 ยท ASV Reactions & Pitfalls

Managing Antivenom Reactions

Early Anaphylactic / Anaphylactoid Reaction
Occurs in up to 20โ€“40% of ASV recipients (mostly anaphylactoid, complement-mediated โ€” not true IgE). Signs: urticaria, itch, fever, cough, bronchospasm, hypotension during/shortly after infusion. Management: STOP/slow the ASV, give adrenaline 0.5 mg IM, IV fluids, oxygen; once settled, restart ASV at a slower rate. Routine prophylactic adrenaline before ASV is supported by some evidence (SC adrenaline) but practice varies โ€” at minimum keep it drawn up. Antihistamines/steroids are adjuncts only.
Pyrogenic Reaction & Late Serum Sickness
Pyrogenic: fever, rigors, hypotension 1โ€“2 h into infusion (endotoxin contamination) โ€” cool, antipyretics, slow the infusion. Serum sickness (type III) at 5โ€“14 days: fever, urticaria, arthralgia, lymphadenopathy, proteinuria โ€” treat with a short course of oral steroids ยฑ antihistamines.
๐Ÿ“˜ "ASV Failure" โ€” Think Before Escalating

If a patient is not responding to repeated ASV, consider: (1) species not covered by polyvalent ASV (e.g. hump-nosed pit viper); (2) the damage is already done (established AKI, necrosis โ€” ASV neutralises circulating venom, it does not reverse fixed tissue injury); (3) pre-synaptic neurotoxin (krait/Russell's) where recovery depends on nerve-terminal regeneration and time on the ventilator, not more ASV; (4) wrong diagnosis. Endlessly escalating vials beyond the effective ceiling adds reaction risk without benefit.

โŒ 7 ยท Common Mistakes

Common Mistakes in Snakebite Management

โŒ Mistake 1 โ€” Applying a Tight Tourniquet

Tourniquets cause limb ischaemia and gangrene, and releasing them can deliver a sudden bolus of venom systemically. They are not recommended. Use pressure immobilisation/splinting and rapid transport instead. If a tourniquet is already on, release it slowly only after assessing for envenomation and readiness to treat.

โŒ Mistake 2 โ€” Giving ASV for Every Bite

ASV carries a high reaction rate and is a scarce resource. It is indicated only for systemic or severe local envenomation. Many bites are dry or by non-venomous snakes โ€” observe and use the 20-WBCT and neurological signs to decide, rather than treating the bite reflexively.

โŒ Mistake 3 โ€” Reducing the ASV Dose for Children

Children receive the same number of vials as adults โ€” the venom dose injected is the same regardless of the victim's size. Under-dosing a child is a serious and common error.

โŒ Mistake 4 โ€” Missing the Delayed Krait Bite

Krait bites often occur during sleep, may leave no visible mark or local swelling, and present hours later with abdominal pain, ptosis and respiratory failure. Failing to suspect neurotoxic envenomation in such a presentation can be fatal โ€” always check for ptosis and bulbar weakness.

โŒ Mistake 5 โ€” IM Injections / Procedures While Coagulopathic

Giving IM tetanus toxoid, doing arterial punctures, inserting central lines or performing early fasciotomy in a coagulopathic patient causes uncontrollable bleeding. Correct coagulopathy with ASV first; reserve fasciotomy for confirmed compartment syndrome after coagulation is restored.

โŒ Mistake 6 โ€” Relying on Neostigmine in Pre-Synaptic Envenomation

Neostigmine helps post-synaptic (cobra) neurotoxicity but is largely ineffective against pre-synaptic toxins (krait, Russell's viper). Do not delay or substitute ventilatory support waiting for a neostigmine response โ€” airway and ventilation are what save these patients while they recover.

๐Ÿ“‘ 8 ยท References

References

  1. Tintinalli JE, Ma OJ, Yealy DM et al. Tintinalli's Emergency Medicine: A Comprehensive Study Guide, 9th Ed. Chapter: Reptile Bites. McGraw-Hill; 2020.
  2. Walls RM, Hockberger RS, Gausche-Hill M et al. Rosen's Emergency Medicine: Concepts and Clinical Practice, 10th Ed. Chapter: Reptile Envenomations. Elsevier; 2023.
  3. Government of India, Ministry of Health & Family Welfare. National Snakebite Management Protocol (India), 2009; Standard Treatment Guidelines for Snakebite (updated 2017).
  4. World Health Organization, Regional Office for South-East Asia (SEARO). Guidelines for the Management of Snakebites, 2nd Ed. WHO-SEARO; 2016.
  5. Warrell DA. Snake bite. Lancet 2010;375:77โ€“88.
  6. Mohapatra B, Warrell DA, Suraweera W et al. Snakebite mortality in India: a nationally representative mortality survey (Million Death Study). PLoS Negl Trop Dis 2011;5:e1018.
  7. Indian Council of Medical Research (ICMR). Snakebite management guidance & antivenom research initiatives.